These previous reports collectively demonstrate that SUSD2 serves two-sided functions, such as pro-tumoral or anti-tumoral ones, depending on cancer type, including hepatocellular carcinoma, breast cancer, renal cell carcinoma, lung cancer, and ovarian cancer [11,28,29,30,31]. This evidence concerns the gene SUSD2 and lung carcinoma.